Systematic review of the diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in melanoma patients

Cancer

Volumn 91, Issue 8, 2001, Pages 1530-1542

  Mijnhout, G Sophie ^a   Hoekstra, Otto S ^a   Van Tulder, Maurits W ^b   Teule, Gerrit J J ^b   Devillé, Walter L J M ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

18F fluorodeoxyglucose; Melanoma; Positron emission tomography; Systematic review

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER STAGING; DATA BASE; DIAGNOSTIC ACCURACY; HUMAN; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SKIN METASTASIS;

EID: 0035871377     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010415)91:8<1530::aid-cncr1162>3.0.co;2-%23     Document Type: Article

References (33)

1. PET in oncology: Will it replace the other modalities?
2. When and how to assess fast-changing technologies: A comparative study of medical applications of four generic technologies
3. Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic melanoma
4. Effectiveness of positron emission tomography for the detection of melanoma metastases
5. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma
6. Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma
7. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography. Results of a prospective study of 100 patients
8. Positron emission tomography in the detection and management of metastatic melanoma
9. Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma
10. Malignant melanoma: Staging with wholebody positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose
11. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma
12. Planar coincidence scintigraphy and PET in staging malignant melanoma
13. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy
14. Positron emission tomography: Establishing priorities for health technology assessment
15. Guidelines for meta-analyses evaluating diagnostic tests
16. How to perform a comprehensive search for FDG-PET literature?
17. Users' guides to the medical literature. III. How to use a article about a diagnostic test. A. Are the results of the study valid? Evidence-based working group
18. Use of methodological standards in diagnostic test research
19. The identification of bias in studies of the diagnostic performance of imaging modalities
20. Assessing quality of a diagnostic test evaluation
21. Publications on diagnostic test evaluation in family medicine journals: An optimal search strategy
22. The periodic health examination
23. A meta-analytic method for summarizing diagnostic test performances: Receiver-operating-characteristics-summary point estimates
24. Combining independent studies of a diagnostic test into a summary ROC curve: Data-analytic approaches and some additional considerations
25. Meta-analytic methods for diagnostic accuracy
26. Empirical evidence of design-related bias in studies of diagnostic tests
27. Measuring the effects of imaging: An evaluative framework
28. The efficacy of diagnostic imaging
29. Evaluating and comparing imaging techniques: A review and classification of study designs
30. Clinical efficacy of computed body tomography II